Journal of Traditional Chinese Medicine >
Effects of Qizhukangxian granules on idiopathic pulmonary fibrosis: a randomized, double blind, placebo-controlled and multicenter clinical pilot trial
Online published: 2020-08-15
Supported by
the Tianjin Natural Science Foundation:Mechanism Research of Yiqixiaoyu Therapy on Preventing and Treating idiopathic pulmonary fibrosis (IPF) by Regulating Alveolar Epithelial Injury via Targeting Multi-signal Pathways (No. 16JCQNJC11200), National Natural Science Foundation of China:Delineating the Compatibility Effects and the Synergistic Advantages of Yiqipoyuxiaotan Therapy in IPF Based on Regulating TypeⅡ Alveolar Epithelial Cell Autophagy and Lung Fibroblast Glycolysis (No. 81874398), Tianjin Municipal Education Commission Project:The University Innovation Team Developing Program (No.TD13-5051), Tianjin Science and Technology Plan Project:Tianjin Traditional Chinese Internal Medicine Clinical Research Center (No. 15ZXLCSY00020)
Guo Sijia, Song Yalin, Feng Jihong, Liu Shuang, Li Yuechuan, Liu Min, Wei Luqing, Zhang Xian, Xie Hui, Sun Zengtao . Effects of Qizhukangxian granules on idiopathic pulmonary fibrosis: a randomized, double blind, placebo-controlled and multicenter clinical pilot trial[J]. Journal of Traditional Chinese Medicine, 2020 , 40(4) : 674 -682 . DOI: 10.19852/j.cnki.jtcm.2020.04.017
/
| 〈 |
|
〉 |